[¿Cómo se relaciona la obesidad con la pandemia COVID-19?]

Gutt, Susana.
Rev. Hosp. Ital. B. Aires (2004) ; 40(2): 56-57, jun. 2020. ilus
Artículo en Español | LILACS | ID: biblio-1102486

Documentos relacionados

  1. Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis.
  2. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
  3. Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity.
  4. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.
  5. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
  6. Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice.
  7. Postdischarge venous thromboembolism following hospital admission with COVID-19.
  8. Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19.
  9. Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity.
  10. Clinical Outcomes of Acute Pancreatitis in Patients With Coronavirus Disease 2019.